Novartis Consumer Health Inc. voluntarily recalled some lots of Excedrin pain reliever and other OTC products in hopes of minimizing the damage from quality control failures at its Lincoln, Neb., production facility.
How widespread or costly these issues will prove for the Novartis AG business is unclear. But the Swiss firm is taking early control of the situation to avoid the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?